Managing CBD-Related Drug Test Failures in Kentucky Workplaces
Guidance for Kentucky employers on handling CBD-linked positive drug tests while preserving safety, compliance, and fairness.

Cannabidiol (CBD) products are now widely available, and many employees use them for pain, anxiety, or general wellness. Yet even when workers believe they are using “legal CBD,” some still test positive for THC on workplace drug screens. For Kentucky employers, CBD-related positive tests raise difficult questions: how to respond, what the law allows, and how to balance safety with fairness.
This article offers a structured approach for Kentucky employers to manage CBD-linked drug test failures, design clear policies, and reduce legal and operational risk. It focuses on general information and practical steps rather than any specific worker or case.
1. Why CBD Creates Challenges for Employer Drug Testing
CBD itself is not typically the target of standard workplace drug tests; most panels look for tetrahydrocannabinol (THC), the psychoactive component in cannabis. However, many CBD oils, edibles, and other products contain trace amounts of THC, and in some cases more than the label suggests. That can lead to a positive test for cannabis even when the employee believed they were using THC-free CBD.
- Labeling issues: Some CBD products are inaccurately labeled or contaminated, causing unintended THC exposure.
- Testing thresholds: Common immunoassay tests screen for THC metabolites at set cut-off levels; repeated or high-dose CBD use may push levels over these thresholds if THC is present.
- Employee assumptions: Workers often assume that “legal CBD” cannot affect a drug test, which is not always true.
As a result, employers in Kentucky who maintain drug-free workplace programs must decide in advance how to treat CBD-related positives to avoid inconsistent or perceived unfair treatment.
2. Overview of Kentucky Drug-Free Workplace Framework
Kentucky allows employers to adopt a formal drug-free workplace program, which can qualify certain employers for workers’ compensation premium credits when they comply with statutory and regulatory requirements. These programs are governed by state statutes and administrative regulations and typically require:
- A written drug and alcohol policy distributed to employees with signed acknowledgments.
- Employee education and annual supervisor training on substance use and impairment.
- Use of an 11-panel drug test processed by a SAMHSA-certified laboratory, together with review by a medical review officer (MRO).
- Defined testing triggers such as post-offer, random, reasonable suspicion, post-accident, and follow-up testing.
- Confidential handling and separate storage of testing records from general personnel files.
Employers who meet these requirements and obtain certification from the Kentucky Department of Workers’ Claims may receive a discount (commonly 5%) on their workers’ compensation premiums. In exchange, they must consistently enforce their policy, including how positive test results are addressed.
3. Interaction with Kentucky’s Medical Cannabis Law
Kentucky has enacted a medical cannabis law that is scheduled to become fully effective in early 2025, and this development adds complexity to CBD and cannabis-related workplace issues. The law:
- Permits medical cannabis use under specific conditions and for defined medical diagnoses.
- Does not require employers to allow cannabis use, possession, or impairment in the workplace, even for registered patients.
- Affirms that employers may maintain or implement drug-free workplace and zero-tolerance policies, including testing for cannabis.
- Allows employers to test cardholding employees they reasonably and in good faith believe are impaired, based on behavioral observations and test results.
- States that discharge for violating workplace drug policies can disqualify an employee from unemployment insurance benefits.
Because CBD products may contain THC, a positive test may not distinguish between medical cannabis, recreational use, or contaminated CBD. Employers therefore need policies and procedures that focus on conduct and compliance, rather than trying to parse all possible sources of THC.
4. Establishing Clear Written Policies that Address CBD
Whether or not an employer participates in the certified drug-free workplace program, Kentucky guidance emphasizes having a clear written drug testing policy distributed to employees before testing begins. To address CBD-related issues, that policy should explicitly speak to cannabis and related products.
Core policy elements that can help manage CBD-related positives include:
- Scope of prohibited substances: Clearly state that the policy covers illegal drugs and controlled substances, including THC and cannabis-derived products, except as lawfully prescribed and specifically allowed by the policy.
- Statement about CBD: Explain that CBD products may cause positive THC results and that a positive test for THC will be treated as a positive for cannabis, regardless of claimed CBD use.
- Testing circumstances: Describe when tests can occur (pre-employment post-offer, random, reasonable suspicion, post-accident, follow-up), in line with Kentucky requirements if seeking certification.
- Consequences of positive tests: Outline potential outcomes, such as removal from duty, referral to evaluation or counseling, last-chance agreements, or termination, and when each may apply.
- Employee assistance options: If an Employee Assistance Program (EAP) is available, describe how employees can access support for substance use issues.
- Confidentiality commitments: Reassure employees that test results are kept confidential and stored separately, with access limited to those with a need to know.
Providing this information in advance, ideally 60–90 days before testing begins, also allows employees to seek help or adjust their use of substances, including CBD, before they face sanctions for a positive test.
5. Step-by-Step Response When a Worker Fails a Drug Test
When a Kentucky employee fails a drug test and attributes the result to CBD use, employers should follow a structured, documented process. This helps maintain consistency and supports decisions if later challenged.
5.1 Confirm the Test Result and Review by a Medical Review Officer
For certified programs, laboratory analysis and review by a medical review officer (MRO) are standard. Before acting, confirm:
- That the laboratory is SAMHSA-certified and followed proper chain-of-custody procedures.
- That the test was confirmed (usually via GC/MS or similar confirmatory method) after an initial screen.
- That the MRO has contacted the employee to review any lawful prescriptions or plausible explanations.
This stage ensures the employer is acting on a reliable result, not a preliminary or unconfirmed screen.
5.2 Document the Employee’s Explanation
If the employee claims the positive result was caused by CBD, the employer should document this statement in writing. Ask the employee:
- What products they used (brand, dosage, frequency).
- Whether they hold a medical cannabis registration card.
- Whether any licensed health care provider recommended or prescribed cannabinoid products.
Although this information does not necessarily change the outcome under a zero-tolerance policy, it may guide whether to offer an EAP referral, a last-chance agreement, or other support.
5.3 Apply the Policy Consistently
Once the employer has a confirmed positive and a written explanation, it should apply the consequences outlined in the policy without favoritism or discrimination. For example:
- If the policy states that any positive THC test for a safety-sensitive position results in termination, the same consequence should apply whether the employee used CBD, medical cannabis, or recreational marijuana.
- If the policy allows first-time offenders to enter rehabilitation with follow-up testing, that option can be offered regardless of the specific product used.
Consistency is critical both for employee morale and for defending decisions in administrative or judicial proceedings.
5.4 Consider Role-Based Risks and Public Safety
Kentucky guidance recognizes that safety-sensitive positions may warrant stricter rules and random testing, particularly in public employment. Roles such as commercial drivers, heavy equipment operators, and first responders pose heightened risks if an employee is impaired. In these cases:
- Removal from duty after a positive test may be necessary to protect co-workers and the public.
- Return-to-duty decisions should include evidence of rehabilitation, negative follow-up tests, and possibly fitness-for-duty evaluations.
Employers should reflect these heightened expectations in their written policies and training programs.
6. CBD, ADA, and Disability Considerations
Some employees use CBD to manage conditions that may qualify as disabilities under the Americans with Disabilities Act (ADA), such as chronic pain or anxiety. Kentucky legal analysis notes that while the underlying medical condition may require reasonable accommodation, employers are not required to accommodate the use of medical cannabis in the workplace.
Key points for employers navigating CBD and disability issues include:
- Engage in the interactive process: When an employee discloses a medical condition, discuss possible accommodations that do not involve workplace impairment or violation of drug policies.
- Separate condition from conduct: Distinguish between accommodating a disability and excusing policy violations such as testing positive for THC while subject to a zero-tolerance rule.
- Apply policies neutrally: Avoid imposing harsher sanctions on disabled employees than on non-disabled employees for the same violation.
CBD use may be part of a worker’s medical regimen, but that does not automatically override employer drug policies—especially where safety and regulatory compliance are at stake.
7. Communication, Education, and Prevention
Employers can reduce misunderstandings and grievances over CBD-related positives by investing in communication and training. Kentucky’s certified drug-free workplace framework already emphasizes education and supervisor training.
Effective preventive measures include:
- Employee education sessions: Explain how drug testing works, that CBD products can contain THC, and that the policy treats confirmed THC positives as cannabis use.
- Supervisor training: Teach supervisors how to recognize possible impairment, document reasonable suspicion, and avoid making medical judgments they are not qualified to make.
- Written FAQs and policy summaries: Provide accessible, plain-language materials answering common questions about CBD, cannabis, and testing.
By making expectations clear, employers help workers make informed choices about CBD use and reduce surprise when a test comes back positive.
8. Practical Policy Options for Handling CBD-Related Positives
Different workplaces will choose different approaches depending on their industry, safety profile, and culture. Below is a comparison of common policy models:
| Policy Model | Key Features | Advantages | Considerations |
|---|---|---|---|
| Strict Zero-Tolerance | Any confirmed THC positive results in disciplinary action up to termination, regardless of CBD claims or medical use. | Clear expectations; strong safety focus; supports certified drug-free workplace standards. | Limited flexibility; may raise employee relations concerns and require careful ADA analysis. |
| Conditional Second-Chance | First confirmed positive leads to removal from duty and mandatory evaluation or rehabilitation, with frequent follow-up tests. | Shows commitment to rehabilitation; may reduce turnover; still protects safety through monitoring. | Requires strong EAP and follow-up infrastructure; must be applied consistently. |
| Role-Based Approach | Stricter rules for safety-sensitive positions; more flexible options for low-risk roles. | Aligns policy with actual risk; recognizes diverse job functions. | Needs clear criteria for “safety-sensitive” and transparent communication to avoid perceptions of favoritism. |
Whichever model is chosen, employers should incorporate CBD considerations explicitly so employees understand how their use may be treated.
9. Kentucky-Specific Compliance Tips
To align with Kentucky’s legal framework while managing CBD-related drug test failures, employers should keep several state-specific points in mind:
- Certification requirements: For those seeking workers’ compensation premium credits, ensure your program meets the requirements in Kentucky law and regulations, including testing triggers, written policy, EAP, and confidentiality measures.
- Public employer limitations: Municipal and other public employers should note that random testing is often limited to safety-sensitive positions, while reasonable suspicion, pre-employment post-offer, and post-accident testing are more broadly permitted.
- Unemployment implications: Employees discharged for violating drug-free workplace policies, including cannabis rules, may be disqualified from unemployment benefits if the conduct constitutes misconduct under Kentucky law.
- Federal overlay: Employers subject to federal drug-testing mandates (for example, under U.S. Department of Transportation rules) must comply with those requirements in addition to state law, and CBD-related positives may have federal consequences.
10. Frequently Asked Questions
Does Kentucky law require employers to allow CBD use?
No. Kentucky law does not obligate employers to allow CBD or cannabis use in the workplace. Employers may adopt and enforce drug-free and zero-tolerance policies, subject to applicable state and federal rules.
Can an employee avoid discipline by saying the positive test came from CBD?
Generally, if a written policy treats any confirmed THC positive as a violation, an employee’s claim that the result came from CBD does not automatically prevent discipline. Employers should still confirm results through a certified lab and MRO and apply their policy consistently.
Are Kentucky employers allowed to test medical cannabis cardholders?
Yes. Kentucky’s medical cannabis law allows employers to continue testing for cannabis and to act on positive results, including for cardholding employees they reasonably believe to be impaired.
Should employers mention CBD directly in their policies?
It is prudent to do so. Explicitly explaining that CBD products can cause THC positives and that such results will be treated as cannabis use helps manage expectations and reduce disputes.
What steps help minimize legal risk when disciplining someone who used CBD?
Key steps include using certified testing, confirming results, documenting the employee’s explanation, applying written policies consistently, considering safety-sensitive status, and engaging in ADA-compliant accommodation discussions about underlying conditions rather than substance use itself.
References
- Kentucky Drug-Free Workplace Program — ASAP Programs (summary of Kentucky statutes and regulations). 2023-06-01. https://www.asap-programs.com/kentucky-drug-free-workplace-program
- Drug Free Workplace — Kentucky Education and Labor Cabinet. 2022-09-15. https://elc.ky.gov/Workers-Compensation/Pages/Drug-Free-Workplace.aspx
- Title 803 Chapter 25 Regulation 280 – Drug-Free Workplace Programs — Kentucky Administrative Regulations. 2020-01-03. https://apps.legislature.ky.gov/law/kar/titles/803/025/280/
- Drug Testing for Public Employees — Kentucky League of Cities. 2021-04-12. https://www.klc.org/News/8324/drug-testing-for-public-employees
- 5 Things Kentucky Employers Need to Know About the State’s New Medical Cannabis Law — Fisher Phillips. 2023-04-06. https://www.fisherphillips.com/en/insights/insights/kentucky-employers-medical-cannabis-law
Read full bio of Sneha Tete










